BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 233 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $46,000 | +53.3% | 568 | +42.0% | 0.01% | +125.0% |
| Q1 2019 | $30,000 | -90.7% | 400 | -90.2% | 0.00% | -93.3% |
| Q3 2018 | $321,000 | +3.2% | 4,100 | -19.6% | 0.06% | -15.5% |
| Q2 2018 | $311,000 | +498.1% | 5,100 | +750.0% | 0.07% | +446.2% |
| Q1 2018 | $52,000 | -55.9% | 600 | -64.7% | 0.01% | -50.0% |
| Q3 2017 | $118,000 | -82.2% | 1,700 | -89.8% | 0.03% | -65.8% |
| Q1 2017 | $664,000 | +538.5% | 16,604 | +345.9% | 0.08% | +484.6% |
| Q4 2016 | $104,000 | – | 3,724 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |